Breier A, Stefanková Z, Barancík M, Tribulová N
Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava.
Gen Physiol Biophys. 1994 Aug;13(4):287-98.
Overexpression of P-glycoprotein (P-GP) accompanied by multidrug resistance (MDR) to diverse groups of cytostatics was developed by long-term adaptation of mouse leukemic cell line L1210 to vincristine. Two resistant sublines of cells characterized by ID50 values for vincristine 1.05 mg/l (L1210/VCR-1) and 2.3 mg/l (L1210/VCR-2), respectively, were used. The sensitive parental cell line L1210 had the ID50 value for vincristine around 0.01 mg/l. Overexpression of P-GP induced by the adaptation procedure was found to be accompanied by an increase in the mean cell diameter from 10.28 +/- 1.60 microns (mean +/- SD, n = 122) for sensitive L1210 cells to 17.82 +/- 2.59 microns (n = 120) and 37.26 +/- 5.72 microns (n = 121) for L1210/VCR-1 and L1210/VCR-2 resistant cell sublines, respectively. Significant decrease in ability to accumulate [3H]-vincristine from cultivation medium was observed for both resistant cell sublines in comparison to sensitive cells. Accumulation of [3H]-vincristine by sensitive cells is secured only by passive diffusion of the drug across the plasma membrane. Contrary to that, active efflux of drug operating against its diffusion across the plasma membrane should be assumed as a factor influencing the [3H]-vincristine accumulation by resistant cells. Indeed, the time dependence of [3H]-vincristine accumulation by sensitive cells could be fitted using simple monoexponential kinetic dependence in contrast to biexponential kinetic dependences that are necessary for fitting [3H]-vincristine accumulation by both resistant cell sublines. Kinetic analysis of the experimental data indicates that accumulation of [3H]-vincristine by sensitive cells grows to a plateau reflecting probably the equilibrium of drug concentration in the intracellular and extracellular space. On the contrary, accumulation of [3H]-vincristine by both resistant cell sublines was stabilized after an initial growth on a considerably lower level than it was observed for the sensitive cells in the equilibrium.
通过将小鼠白血病细胞系L1210长期适应长春新碱,培育出了伴有对多种细胞抑制剂多药耐药(MDR)的P-糖蛋白(P-GP)过表达。使用了两个耐药细胞亚系,其对长春新碱的ID50值分别为1.05 mg/l(L1210/VCR-1)和2.3 mg/l(L1210/VCR-2)。敏感的亲本细胞系L1210对长春新碱的ID50值约为0.01 mg/l。发现适应过程诱导的P-GP过表达伴随着平均细胞直径的增加,从敏感的L1210细胞的10.28 +/- 1.60微米(平均值 +/- 标准差,n = 122)分别增加到L1210/VCR-1和L1210/VCR-2耐药细胞亚系的17.82 +/- 2.59微米(n = 120)和37.26 +/- 5.72微米(n = 121)。与敏感细胞相比,两个耐药细胞亚系从培养基中积累[3H]-长春新碱的能力均显著降低。敏感细胞积累[3H]-长春新碱仅通过药物被动扩散穿过质膜来实现。与此相反,应假定药物的主动外排作用于其穿过质膜的扩散,这是影响耐药细胞积累[3H]-长春新碱的一个因素。实际上,敏感细胞积累[3H]-长春新碱的时间依赖性可以用简单的单指数动力学依赖性来拟合,这与两个耐药细胞亚系积累[3H]-长春新碱所需的双指数动力学依赖性形成对比。对实验数据的动力学分析表明,敏感细胞积累[3H]-长春新碱增长至平稳期,这可能反映了细胞内和细胞外空间药物浓度的平衡。相反,两个耐药细胞亚系积累[3H]-长春新碱在初始增长后稳定在比敏感细胞平衡期观察到的水平低得多的水平。